Queen Mary University of London has opened up a new research center aiming to revolutionize medical research and drug development using microengineered Organs-on-Chips.
What are Organs-on-Chips?
These devices contain tiny hollow channels lined by human living cells that recreate the microenvironment experienced by cells within the human body. As miniaturized living systems with human cells, Organs-on-Chips can predict human response with greater precision and detail than today’s cell culture or animal-based testing, and can be used in a laboratory to test drugs and understand how the body works.
Market forecasts predict that the organ-on-a-chip market can expect a compound annual growth rate of 38-57 percent over the next five years, rapidly becoming a multi-billion dollar market. This new Queen Mary - Emulate Organs-on-Chips Centre is at the forefront of this activity in the UK. Organs-on-Chips technology is a rapidly expanding field with major pharmaceutical companies now investing in using these systems for drug discovery and development.
Queen Mary—Emulate Organs-on-Chips Centre
This new center will use Organs-on-Chips to recreate the human biology of diff...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).